Cream for treating infant eczema

Abstract

The invention provides a cream for treating infant eczema. The cream comprises a traditional Chinese medicine component and a cream matrix component, wherein the traditional Chinese medicine component comprises the following raw materials by weight: 5-50 parts of radix stephaniae tetrandrae, 5-50 parts of milkvetch root, 1-30 parts of honeysuckle, 1-30 parts of chamomilia, 1-30 parts of lithospermum erythrorhizon sieb. et zucc, 1-30 parts of angelica sinensis, 0.01-5 parts of cornmint oil, 0.01-5 parts of borneol, and 1-50 parts of sesame oil, and the cream matrix component comprises the following raw materials by weight: 5-35 parts of organic silicone oil, 1-25 parts of glycerol, 1-25 parts of mineral oil, 0.01-10 parts of polyethylene glycol, 0.01-10 parts of sodium stearate, 0.1-5 parts of sodium hydroxide, 1-15 parts of a thickening agent, and the balance of deionized water. A purpose of the present invention is to produce the Chinese herb cream suitable for infants and young children for a long time, wherein the Chinese herb cream is used for prevention and relieving skin allergic reactions such as eczema, diaper rash, mosquito bite and the like in infants and young children.

Description

technical field [0001] This patent relates to the pharmaceutical field, in particular to a cream for treating infantile eczema. Background technique [0002] Infant eczema is common in breastfeeding children under 1 year old, so it is also called "milk ringworm". It is a common allergic skin inflammatory disease caused by various internal and external factors. It mostly occurs on the face and neck of infants and young children, and when it is severe, it involves the trunk and limbs, showing pleomorphic lesions dominated by papules, with a tendency to exudate and accompanied by severe itching. Children often have repeated attacks, and the acute and chronic phases overlap alternately. Once suffering from tinea milk, it will not only affect the children's appearance, but also seriously affect their daily life. What's more, the skin will be scratched due to itching, causing more serious conditions such as skin infection. At present, the clinical treatment of infant eczema is d...

AI Technical Summary

Problems solved by technology

At present, the clinical treatment of infant eczema is divided into oral and external use. Oral use is mostly antihistamine drugs. Long-term use can cause side effects such as drowsiness and low immunity, and has liver and kidney toxicity; Use will affect the immunity of children and cause adverse reactions such as skin shrinkage in the affected area

And other Chinese herbal ointments for external use, such as licorice, etc., the active ingredient glycyrrhetinic acid is similar in structure to glucocorticoids, which is not conducive to long-term use in children

Images